NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

前部葡萄膜炎治療的全球市場:各治療類型,各流通管道的預測(到2025年)- COVID-19累積的影響

Anterior Uveitis Treatment Market Research Report by Treatment Type, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 990532
出版日期 內容資訊 英文 198 Pages
商品交期: 最快1-2個工作天內
價格
前部葡萄膜炎治療的全球市場:各治療類型,各流通管道的預測(到2025年)- COVID-19累積的影響 Anterior Uveitis Treatment Market Research Report by Treatment Type, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 198 Pages
簡介

全球前部葡萄膜炎治療的市場規模,預計從2020年的2億159萬美元,擴大至2025年末達2億8,982萬美元。

COVID-19是影響幾乎全部產業的無與倫比的世界公共衛生緊急事件,在預測期間內預計帶給產業的成長長期性的影響。

本報告提供全球前部葡萄膜炎治療市場的相關調查,市場機會和課題,成長及阻礙因素,COVID-19累積的影響,各治療類型、流通管道、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 調查目的
  • 市場區隔和涵蓋範圍
  • 調查期間
  • 貨幣和價格
  • 語言
  • 規定事項
  • 利害關係者

第2章 調查方法

  • 調查流程
    • 定義:調查目的
    • 決策:調查計劃
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 製作計劃:調查計劃
    • 實施實行:調查
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 簡介
  • 市場展望
  • 各治療類型市場展望
  • 各流通管道市場展望
  • 各地區市場的展望
  • 其他競爭公司的展望

第4章 市場概要

  • 簡介
  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析

第6章 各治療類型市場

  • 簡介
  • 抗TNF劑
  • 皮質類固醇
  • 睫狀體筋麻痺藥
  • 免疫抑制劑

第7章 各流通管道市場

  • 簡介
  • 醫院藥局
  • 線上藥局
  • 零售藥局

第8章 南北美洲市場

  • 簡介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區市場

  • 簡介
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲,中東、非洲市場

  • 簡介
  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 評估,認識,擴大

第12章 企業簡介

  • AbbVie Inc.
  • Aciont Inc.
  • Akorn Pvt. Ltd
  • Aldeyra Therapeutics, Inc.
  • Alimera Sciences Inc.
  • Amdipharm Mercury Company Limited
  • Amgen Inc.
  • Bausch & Lomb Incorporated
  • Clearside Biomedical, Inc.
  • Enzo Biochem Inc
  • Enzo Biochem Inc.
  • Eyegate Pharmaceuticals, Inc.
  • Hanall Biopharma
  • Lux Biosciences, Inc
  • Novartis AG
  • Ophthalix Inc
  • Regeneron Pharmaceuticals, Inc.
  • 參天製藥
  • 千壽製藥
  • Sirion Therapeutics, Inc.
  • TopiVert Pharma Limited
  • UAB Medicine
  • UCB Biopharma S.P.R.L.
  • Wize Pharma Inc
  • Xoma Corporation

第13章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-ED54C46E9121

The Global Anterior Uveitis Treatment Market size was estimated at USD 201.59 Million in 2020 and expected to reach USD 217.77 Million in 2021, at a Compound Annual Growth Rate (CAGR) 8.36% to reach USD 326.51 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Anterior Uveitis Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Treatment Type, the Anterior Uveitis Treatment Market was studied across Anti-TNF Agents, Corticosteroids, Cycloplegic Agents, and Immunosuppressants.

Based on Distribution Channel , the Anterior Uveitis Treatment Market was studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.

Based on Geography, the Anterior Uveitis Treatment Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Anterior Uveitis Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Anterior Uveitis Treatment Market, including AbbVie Inc., Aciont Inc., Akorn Pvt. Ltd, Aldeyra Therapeutics, Inc., Alimera Sciences Inc., Amdipharm Mercury Company Limited, Amgen Inc., Bausch & Lomb Incorporated, Clearside Biomedical, Inc., Enzo Biochem Inc, Enzo Biochem Inc., Eyegate Pharmaceuticals, Inc., Hanall Biopharma, Lux Biosciences, Inc, Novartis AG, Ophthalix Inc, Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Senju Pharmaceutical Co. Ltd, Sirion Therapeutics, Inc., TopiVert Pharma Limited, UAB Medicine, UCB Biopharma S.P.R.L., Wize Pharma Inc, and Xoma Corporation.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Anterior Uveitis Treatment Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Anterior Uveitis Treatment Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Anterior Uveitis Treatment Market?
  • 4. What is the competitive strategic window for opportunities in the Global Anterior Uveitis Treatment Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Anterior Uveitis Treatment Market?
  • 6. What is the market share of the leading vendors in the Global Anterior Uveitis Treatment Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Anterior Uveitis Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Treatment Type Outlook
  • 3.4. Distribution Channel Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of eye infections
      • 5.1.1.2. Rising expenditure on the research and development of novel drugs and treatments for Uveitis
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the medications
      • 5.1.2.2. Limited knowledge about eye disorders
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of research companies on biological drugs
      • 5.1.3.2. Growing demand for drugs such as corticosteroids and anti-inflammatory medications in developing countries
    • 5.1.4. Challenges
      • 5.1.4.1. Side effect associated with corticosteroid treatment
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Anterior Uveitis Treatment Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Anti-TNF Agents
  • 6.3. Corticosteroids
  • 6.4. Cycloplegic Agents
  • 6.5. Immunosuppressants

7. Anterior Uveitis Treatment Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospital Pharmacies
  • 7.3. Online Pharmacies
  • 7.4. Retail Pharmacies

8. Americas Anterior Uveitis Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Anterior Uveitis Treatment Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Anterior Uveitis Treatment Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. AbbVie Inc.
  • 12.2. Aciont Inc.
  • 12.3. Akorn Pvt. Ltd
  • 12.4. Aldeyra Therapeutics, Inc.
  • 12.5. Alimera Sciences Inc.
  • 12.6. Amdipharm Mercury Company Limited
  • 12.7. Amgen Inc.
  • 12.8. Bausch & Lomb Incorporated
  • 12.9. Clearside Biomedical, Inc.
  • 12.10. Enzo Biochem Inc
  • 12.11. Enzo Biochem Inc.
  • 12.12. Eyegate Pharmaceuticals, Inc.
  • 12.13. Hanall Biopharma
  • 12.14. Lux Biosciences, Inc
  • 12.15. Novartis AG
  • 12.16. Ophthalix Inc
  • 12.17. Regeneron Pharmaceuticals, Inc.
  • 12.18. Santen Pharmaceutical Co., Ltd.
  • 12.19. Senju Pharmaceutical Co. Ltd
  • 12.20. Sirion Therapeutics, Inc.
  • 12.21. TopiVert Pharma Limited
  • 12.22. UAB Medicine
  • 12.23. UCB Biopharma S.P.R.L.
  • 12.24. Wize Pharma Inc
  • 12.25. Xoma Corporation

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2020 (USD MILLION)
  • FIGURE 4. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2026
  • FIGURE 10. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ANTI-TNF AGENTS, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ANTI-TNF AGENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CYCLOPLEGIC AGENTS, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CYCLOPLEGIC AGENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2020 VS 2026 (%)
  • FIGURE 19. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2020 VS 2026 (USD MILLION)
  • FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2026
  • FIGURE 21. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. AMERICAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 28. AMERICAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 30. ARGENTINA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 31. BRAZIL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 32. CANADA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 33. MEXICO ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. UNITED STATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. CALIFORNIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. FLORIDA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. ILLINOIS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. NEW YORK ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. OHIO ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. PENNSYLVANIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. TEXAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. ASIA-PACIFIC ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 43. ASIA-PACIFIC ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 45. CHINA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. INDIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. INDONESIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. JAPAN ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. MALAYSIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. PHILIPPINES ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. SOUTH KOREA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. THAILAND ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. EUROPE, MIDDLE EAST & AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 54. EUROPE, MIDDLE EAST & AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 56. FRANCE ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. GERMANY ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. ITALY ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. NETHERLANDS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. QATAR ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. RUSSIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. SAUDI ARABIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. SOUTH AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. SPAIN ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. UNITED ARAB EMIRATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. UNITED KINGDOM ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: FPNV POSITIONING MATRIX
  • FIGURE 68. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 69. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTERIOR UVEITIS TREATMENT MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ANTI-TNF AGENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY CYCLOPLEGIC AGENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. AMERICAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. AMERICAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. AMERICAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. ARGENTINA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. ARGENTINA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. BRAZIL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. BRAZIL ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. CANADA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. CANADA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. MEXICO ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. MEXICO ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. UNITED STATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. UNITED STATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. UNITED STATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. CALIFORNIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. CALIFORNIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. FLORIDA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. FLORIDA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. ILLINOIS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. ILLINOIS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. NEW YORK ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. NEW YORK ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. OHIO ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. OHIO ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. PENNSYLVANIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. PENNSYLVANIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. TEXAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. TEXAS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. ASIA-PACIFIC ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. ASIA-PACIFIC ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ASIA-PACIFIC ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. CHINA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. CHINA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. INDIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. INDIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. INDONESIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. INDONESIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. JAPAN ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. JAPAN ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. MALAYSIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. MALAYSIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. PHILIPPINES ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. PHILIPPINES ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. SOUTH KOREA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. SOUTH KOREA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. THAILAND ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. THAILAND ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. FRANCE ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. FRANCE ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. GERMANY ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. GERMANY ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. ITALY ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. ITALY ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. NETHERLANDS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. NETHERLANDS ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. QATAR ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. QATAR ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. RUSSIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. RUSSIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. SAUDI ARABIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. SAUDI ARABIA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. SOUTH AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. SOUTH AFRICA ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. SPAIN ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. SPAIN ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. UNITED ARAB EMIRATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. UNITED ARAB EMIRATES ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. UNITED KINGDOM ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. UNITED KINGDOM ANTERIOR UVEITIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: SCORES
  • TABLE 85. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: BUSINESS STRATEGY
  • TABLE 86. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: PRODUCT SATISFACTION
  • TABLE 87. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: RANKING
  • TABLE 88. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 89. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: SHARE, BY COMPANY, 2020
  • TABLE 90. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: MERGER & ACQUISITION
  • TABLE 91. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 92. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 93. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: INVESTMENT & FUNDING
  • TABLE 94. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 95. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: LICENSE & PRICING
  • TABLE 96. GLOBAL ANTERIOR UVEITIS TREATMENT MARKET: CONTACT DETAILS